Evaluation of PD-L1 expression in metachronous tumor samples and FDG-PET as a predictive biomarker in Ph2 study (FIR) of atezolizumab (MPDL3280A) Meeting Abstract
| Authors: | Chaft, J. E.; Chao, B.; Akerley, W. L.; Gordon, M.; Antonia, S. J.; Callahan, J.; Sandler, A.; Funke, R.; Li, Z.; Fredrickson, J.; Kowanetz, M.; Gettinger, S. N. |
| Abstract Title: | Evaluation of PD-L1 expression in metachronous tumor samples and FDG-PET as a predictive biomarker in Ph2 study (FIR) of atezolizumab (MPDL3280A) |
| Meeting Title: | 16th World Conference on Lung Cancer (WCLC) |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 10 |
| Issue: | 9 Suppl. 2 |
| Meeting Dates: | 2015 Sep 6-9 |
| Meeting Location: | Denver, CO |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2015-09-01 |
| Start Page: | S176 |
| Language: | English |
| ACCESSION: | WOS:000370365100218 |
| PROVIDER: | wos |
| PUBMED: | 26710300 |
| DOI: | 10.1016/S1556-0864(16)30010-7 |
| Notes: | Meeting Abstract: ORAL02.06 -- Source: Wos |
